Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2026
      • Abstracts
      • Dates and Deadlines
      • Exhibits
      • Housing and Travel
      • Sessions and Events
      • Registration
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2025
      • Neuroscience 2024
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct for SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2026 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct for SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (1)
  • (3)
  • (4)
  • (122)
  • (2)
  • (1)
  • (6)
Filter
181 - 189 of 189 results
  • Abstract
    d-Methamphetamine (MA) treatment during juvenile and adolescent stages of development induces age-dependent impairments of spatial learning in the Morris water maze.
    We have previously shown that P11-20 treatment with MA induces impaired spatial navigation in the Morris water maze (MWM), whereas P1-10 treatment does not. Little is known about ages after P20 during juvenile and adolescent brain development. In dose-response experiments, we tested successive 10-day intervals of exposure to MA in rats (P21-30, 31-40, 41-50, and 51-60; 4 doses/d). MA-induced toxicity increased with age. Across-age comparisons among the viable dose groups revealed mpaired MWM acquisition after P41-50 MA treatment at the highest dose (6.25 mg/kg/dose). Learning in the Cincinnati water maze (CWM) was also impaired in this group. No effects were seen at 1.25, 2.5 or 5 mg/kg/dose. No MWM acquisition or CWM effects were seen after MA treatment on P21-30 (2.5-10 mg/kg/dose), P31-40 (1.25-7.5 mg/kg/dose), or P51-60 (1.25-5 mg/kg/dose). MWM reversal learning trials after P41-50 treatment showed a trend towards longer latency in all MA dose groups, but no effect after double reversal. Reversal and d...
    Nov 3, 2002
  • Abstract
    A subtle deficit in postsynaptic GABAA receptors results in anxiety-like behavior when present throughout postnatal development but not upon induction in adolescent mice.
    A subtle deficit in postsynaptic GABAARs observed in mice heterozygous for the γ2 subunit is sufficient to reproduce the behavioral, pharmacological, and cognitive hallmarks of generalized anxiety disorder (Crestani et al 1999, Nat. Neurosci. 2, 833-839). To further define the brain substrate involved we have used conditional inactivation of a floxed γ2 (fγ2) gene by means of two different Cre-transgenes that differ in developmental expression patterns. The Emx1Cre transgene induces recombination in the embryo selectively in pyramidal cell neurons and glia of the cortex and hippocampus. Emx1Cre, fγ2/+ mice reproduced the anxiety-like phenotype previously seen in the Free Exploration, Light Dark and Elevated Plus Maze tests upon heterozygous deletion of the γ2 subunit gene in the germ line. Thus, a forebrain-specific GABAAR deficit in glutamatergic neurons mainly in the cerebral cortex and hippocampus induces enhanced behavioral inhibition indicative of pathological anxiety. Fγ2/+ mice expressing a 2nd Cre-...
    Oct 27, 2004
  • Abstract
    Effects of Prenatal Nicotine and Cross-fostering (CF) on the Nucleus Accumbens (Nacc) Dopamine (Da) Response to Acute Nicotine in Adolescent Female Lewis Rats.
    In previous studies, we demonstrated that prenatal nicotine treated female adolescent offspring had a diminished NAcc Da response to 0.07 mg/kg IV nicotine (N). The current studies evaluated the following in adolescent female Lewis pups: (1) the effects of CF and/or prenatal N treatment on N-stimulated (0.07) NAcc Da release; (2) the effect of prenatal N treatment on NAcc Da release in response to 0.105 mg/kg IV N. No N response (0.07) occurred in offspring that received both CF and prenatal N treatment (p>0.05). In contrast, non-CF prenatal N offspring demonstrated an acute Da response to N (p<0.05). This difference in the effect of CF vs. non-CF on NAcc Da release in prenatal N offsping (27% reduction) also was seen in prenatal controls (30% reduction). Conversely, prenatal N attenuated NAcc Da release in both CF (44% reduction; p<0.05) and non-CF groups (47% reduction; p<0.05). In contrast to the lower dose of acute N, 0.105 mg/kg N stimulated NAcc Da release to the same level in non-CF offspring from b...
    Nov 3, 2002
  • Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine | Journal of Neuroscience
    Methylphenidate (MP) (ritalin) is widely used in the treatment of children and adolescents with attention deficit hyperactivity disorder, but little is known about therapeutic mechanisms or about possible consequences of long-term exposure. To more closely simulate the clinical use of the drug, we orally administered MP to adolescent rats during the dark–active phase of the circadian cycle at doses (0.75–3.0 mg/kg) below threshold for locomotor activation. We found that doses in this range increased extracellular norepinephrine in hippocampus without affecting dopamine in nucleus accumbens. These results suggest that norepinephrine systems may play an important role in the therapeutic action of this drug. To examine one potential consequence of long-term exposure to MP, i.e., the development of locomotor sensitization, an adaptational change that has been implicated in drug abuse liability, animals received three daily oral administrations of these doses of MP for up to 4 weeks through adolescence. The ani...
    Aug 15, 2002 Ronald Kuczenski
  • Abstract
    Repeated adolescent methylenedioxymethamphetamine (MDMA, or ecstasy) exposure blunts the serotonin syndrome, but not the hypothermic, response to a 5-HT1A agonist in young adult rats.
    Previous research has demonstrated changes in 5-HT1A receptor density and/or function in adult rats treated with MDMA. The present study determined whether intermittent MDMA exposure during adolescence altered regional 5-HT1A receptor density or the responses to a 5-HT1A receptor agonist given in young adulthood. Male Sprague-Dawley rats (N=48) received 10 mg/kg MDMA or saline during adolescence every fifth day from postnatal day (PD) 35 to 60. MDMA treatment caused a small but significant elevation in core temperature when examined on both PD 35 and PD 60, and it also attenuated the rate of weight gain. On PD 67, animals were challenged with 0.1 or 0.5 mg/kg of the 5-HT1A agonist 8-hydroxy-2-[di-n-propylamino]tetralin (8-OH-DPAT) or saline. Core body temperature was monitored, and the animals were videotaped for subsequent coding of the following serotonin syndrome behaviors: headweaving, forepaw treading, and low body posture. Treatment with 8-OH-DPAT induced a dose-dependent hypothermia that was indepen...
    Nov 12, 2005
  • Abstract
    PRENATAL COCAINE ENHANCES STRESS-INDUCED SERUM CORTICOSTERONE LEVELS IN MALE AND FEMALE ADOLESCENT RATS: NO EFFECT OF GENDER OR INTERACTION WITH SERUM ESTROGEN LEVELS.
    In humans and in animal models, prenatal cocaine has been reported to result in changes to stress responsivity. The effect of stress on serum corticosterone levels has been recently reported only in male, prenatal cocaine-exposed rats (Physiol. & Behav. 72:181, 2001). The response to stress, however, has been proposed to differ with gender, in addition to fluctuations in the estrus cycle in female rats. We examined the effects of prenatal cocaine exposure (3 mg/kg iv, BID, embryonic days 10-20) on hormonal and behavioral responses to stress in both sexes. Adolescent rats (postnatal day 37-38, 1 male & 1 female rat per litter per treatment group) were subjected to 1 of 2 intensities of mild footshock (10 x 0.5 sec over 30 min) and serum samples were taken and analyzed using RIA for corticosterone and, in females, the estrogen, 17-ß-estradiol. Footshock increased serum corticosterone levels in male and female rats in an intensity dependent manner. Prenatal cocaine was associated with a significantly enhanced...
    Nov 12, 2001
  • Abstract
    Gestational nicotine exposure down-regulates the expression of transcripts for selected neuronal nicotinic receptor (nAChR) subunits in the ventral tegmental area (VTA) of adolescent rats.
    We previously reported that gestational nicotine exposure attenuated nicotine-stimulated dopamine release in the nucleus accumbens (NAcc) shell of adolescent rats. In the present study, nAChR subunit mRNA expression was determined in VTA obtained from adolescent rats that had received nicotine during gestation. Timed pregnant Sprague Dawley rats were implanted with osmotic minipumps that constantly infused either nicotine (3mg/kg/day; free base) or sodium bitartrate for 16 days (GD4-21). A total of 16 rats obtained from multiple litters (4F and 4M/treatment) were sacrificed on postnatal day 35. Brains were rapidly removed and frozen sections (15 micron) were prepared. VTA was selectively obtained by laser capture microdissection, which was followed by RNA extraction, DNase treatment and cDNA transcription. Real-time PCR, using SYBR green chemistry, was performed on an ABI7700 instrument. Primers specific for nAChR α 4-7 subunits and dopamine transporter (DAT) were designed to amplify sequences spanning the...
    Oct 23, 2004
  • Effects of Early Life Stress on [11C]DASB Positron Emission Tomography Imaging of Serotonin Transporters in Adolescent Peer- and Mother-Reared Rhesus Monkeys | Journal of Neuroscience
    Peer-reared (PR) rhesus monkeys with early maternal separation later exhibit aggressiveness, impaired impulse control, alcohol abuse, and low CSF 5-hydroxyindoleacetic acid. This study compared regional brain serotonin transporter (SERT) binding between nine PR and seven mother-reared rhesus monkeys with [11C]DASB positron emission tomography (PET) imaging. Parametric images of binding potential (BP) (which is proportional to B max/ K D, in which B max is transporter density and K D is dissociation constant) and relative blood flow ( R 1) were generated by the two-parameter multilinear reference tissue model. R 1 images were used for coregistration and normalization of PET parametric data to the magnetic resonance imaging template space. Group BP differences were analyzed voxelwise by Student's t test in SPM2. Region of interest-based parameter values were also calculated to obtain the magnitude of regional BP differences between the two groups. For the PR group, SERT BP was decreased by 10–23% across a ra...
    Apr 26, 2006 Masanori Ichise
  • Abstract
    A history of peri-adolescent alcohol drinking does not influence the effects of adult alcohol drinking on local cerebral glucose utilization (LCGU) rates in alcohol-preferring (P) rats.
    The objective of the present study was to determine the effects of previous ethanol (E) drinking experience during adolescence by P rats on LCGU rates following chronic E drinking in adulthood. Rats received 24-hr free choice access to 15% E (v/v) and water (W) (N =8) or W only (N=13) from postnatal day 30-60. An average of 7.4 g/kg/day E was consumed over the 30 day free-choice period. Following 2 weeks of W only, animals were given 24-hr free choice access to 15% E or W only for a period of 2 weeks (groups: E + E, W + E, or W + W). On the 15th day rats received an i.v. bolus of [14C]-2-deoxyglucose ([14C]-2-DG) (125 µCi/kg) during the first half of the dark cycle. Timed arterial samples were assayed for glucose, [14C]-2-DG and E content. Brains were quickly removed, snap frozen and 20 µm coronal sections prepared. Image densities were determined using quantitative autoradiography and LCGU values calculated using the operational equation defined by Sokoloff et al (1977). 2 weeks of E drinking resulted in ...
    Oct 27, 2004
  • Previous
  • 17
  • 18
  • 19
  • Next

Featured

  • Get involved with the SfN community
  • Discover what’s new at Neuroscience 2026!
  • Mihaela Iordanova Named Next eNeuro Editor-in-Chief
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Cookie Settings
  • Contact Us

Copyright ©
Society for Neuroscience